Tennis elbow treatment study ends early: what we learned
NCT ID NCT06846593
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a special arm sleeve with embedded semiconductors, combined with injections of platelet-rich plasma and stem cells, could reduce pain and improve elbow function in people with tennis elbow. Only 5 adults aged 18-65 took part before the study was stopped early. The main goal was to measure changes in pain and daily function using standard questionnaires.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
5 people
The number who actually took part.
- Started
-
Nov 2024
- Finished
-
May 2026
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Patients diagnosed with ECRB tendinopathy as determined by radiographic assessment or ultrasound imaging. 2. Patients age 18-65 3. Patients who are willing and able to adhere to follow-up schedule and protocol guidelines. 4. Patients who are willing and able to sign corresponding research subject consent form. Exclusion Criteria: 1. Patient has a history of neurological conditions, including multiple sclerosis or Parkinson's disease 2. Patient has severe medical condition, including recent myocardial infarction, unstable angina, heart failure, severe anemia 3. Patient has had prior surgical treatment of the elbow in the last 5 years or injection treatment(s) in the last 2 years 4. Patient has complete tear of ECRB tendon or other surgical indication 5. Patient has chronic pain conditions unrelated to elbow condition 6. Patient has auto-immune or auto-inflammatory diseases 7. Patient has used tobacco within the last 90 days 8. Patient is not within the ages of 18-65 9. Patient has a history of metabolic disorders 10. Patient has an active infection (local or systemic) 11. Patient is unwilling or unable to sign the corresponding research subject consent form 12. Patient meets any other criteria or has any other condition that, in the opinion of the investigator, would prevent them from completing the study or that, in the opinion of the investigator, would confound study results.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Ecrb tendinopathy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bluetail Medical Group
Chesterfield, Missouri, 63005, United States